MARKET

TELO

TELO

Telomir Pharms
NASDAQ
1.360
-0.060
-4.23%
After Hours: 1.380 +0.02 +1.46% 19:17 01/09 EST
OPEN
1.430
PREV CLOSE
1.420
HIGH
1.440
LOW
1.350
VOLUME
270.72K
TURNOVER
--
52 WEEK HIGH
5.40
52 WEEK LOW
1.120
MARKET CAP
46.76M
P/E (TTM)
-3.6383
1D
5D
1M
3M
1Y
5Y
1D
Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It
Benzinga · 5d ago
Telomir Pharmaceuticals reports results from efficacy study for Telomir-1
TipRanks · 5d ago
Telomir Highlights Positive Preclinical Results for Telomir-1 in TNBC
TipRanks · 5d ago
Telomir Pharmaceuticals Results From Trial In Zebrafish Tumor Xenograft Animal Models Of Triple-Negative Breast Cancer Shows Reductions In Primary Tumor Growth, Spread Of Cancer Cells
Benzinga · 5d ago
TELOMIR PHARMACEUTICALS: TELOMIR-1 SIGNIFICANTLY REDUCED TUMOR GROWTH AND METASTASES IN AGGRESSIVE TRIPLE-NEGATIVE BREAST CANCER ANIMAL MODELS
Reuters · 5d ago
Telomir-1 Reduces Tumor Growth and Spread in Aggressive Triple-Negative Breast Cancer Models
Reuters · 5d ago
Weekly Report: what happened at TELO last week (1229-0102)?
Weekly Report · 6d ago
Weekly Report: what happened at TELO last week (1222-1226)?
Weekly Report · 12/29/2025 09:14
More
About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company is focused on the development of Telomir-1, a novel small molecule metal ion chelator and regulator designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Telomir 1 is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal. Telomir-1 helps protect against age-related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease (a genetic disorder leading to toxic copper buildup in the body), and age-related macular degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer’s disease. It is exploring the potential of Telomir-1 with ongoing research in animals and then in humans. It is focused on developing and commercializing TELOMIR-1, proposed to be dosed orally, with the aim of promoting longevity and enhancing overall quality of life.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.